| NBIIX | RERFX | NBIIX / RERFX | |
| Total Expense Ratio | 0.85 | 0.52 | 163% |
| Annual Report Gross Expense Ratio | 1.03 | 0.52 | 198% |
| Fund Existence | 21 years | 24 years | - |
| Gain YTD | 6.250 | 6.497 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.01B | 137B | 1% |
| Annual Yield % from dividends | 1.19 | 2.75 | 43% |
| Returns for 1 year | 2.13 | 6.58 | 32% |
| Returns for 3 years | 34.46 | 29.93 | 115% |
| Returns for 5 years | -3.75 | 0.70 | -537% |
| Returns for 10 years | 50.46 | 48.47 | 104% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MSGFX | 26.27 | 0.34 | +1.31% |
| Morgan Stanley Inst Global Franchise C | |||
| PBSIX | 20.29 | -0.18 | -0.88% |
| Polen 5Perspectives Small Growth Instl | |||
| JMNAX | 14.01 | -0.18 | -1.27% |
| JPMorgan Research Market Neutral A | |||
| TSNIX | 69.52 | -1.19 | -1.68% |
| T. Rowe Price Science & Tech I | |||
| OBSIX | 39.80 | -0.78 | -1.92% |
| Oberweis Small-Cap Opportunities Instl | |||